ETX-6107

N/A

Report date: 2023/02/11 20:38:18
NME

Base Information

Drug NameETX-6107
Drug Alias NameETS-6107ETX-6107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesE-Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesE-Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A